These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28117622)

  • 1. Solid state characterization, solid dispersions, solubility enhancement, drug dissolution and drug release.
    Alany R
    Pharm Dev Technol; 2017 Feb; 22(1):1. PubMed ID: 28117622
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M; Aguilar-de-Leyva Á; Caraballo I
    Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput automated dissolution method applicable for a wide dose range of controlled release pellets.
    Petruševska M; Horvat M; Peternel L; Kristan K
    Drug Dev Ind Pharm; 2016; 42(7):1149-57. PubMed ID: 26552838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterisation of sustained release solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Shergill M; Patel M; Khan S; Bashir A; McConville C
    Int J Pharm; 2016 Jan; 497(1-2):3-11. PubMed ID: 26608620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release systems containing solid dispersions: strategies and mechanisms.
    Tran PH; Tran TT; Park JB; Lee BJ
    Pharm Res; 2011 Oct; 28(10):2353-78. PubMed ID: 21553168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biorelevant dissolution stress test device - background and experiences.
    Garbacz G; Klein S; Weitschies W
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1251-61. PubMed ID: 20977290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
    Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
    Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Larsson A
    J Pharm Sci; 2011 Jan; 100(1):275-83. PubMed ID: 20572053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fiber distribution model for predicting drug release rates.
    Petlin DG; Amarah AA; Tverdokhlebov SI; Anissimov YG
    J Control Release; 2017 Jul; 258():218-225. PubMed ID: 28526437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - case study of multimodal characterization of quetiapine fumarate tablets.
    Kulinowski P; Woyna-Orlewicz K; Rappen GM; Haznar-Garbacz D; Węglarz WP; Dorożyński PP
    Int J Pharm; 2015 Apr; 484(1-2):235-45. PubMed ID: 25701626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables.
    Meeus J; Scurr DJ; Appeltans B; Amssoms K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G
    Eur J Pharm Biopharm; 2015 Feb; 90():22-9. PubMed ID: 25448071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis.
    Kubova K; Peček D; Hasserová K; Doležel P; Pavelková M; Vyslouzil J; Muselík J; Vetchy D
    Pharm Dev Technol; 2017 Mar; 22(2):206-217. PubMed ID: 28058866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobic weak acid polymers as controlled release carriers.
    Cornejo-Bravo JM; Partida-Soria Y; Serrano-Medina A; Espinoza-Dueñas K; Ramos MA; Licea-Claverie A
    Pharm Dev Technol; 2012; 17(2):170-6. PubMed ID: 21047274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation and characterization of solid dispersions of ginkgolides].
    Ma L; Han L; Zhang Z; Wang J
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1368-72. PubMed ID: 19771864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the in vitro performance of blister molded and conventional lornoxicam immediate release liquitablets: accelerated stability study and anti-inflammatory and ulcerogenic effects.
    El-Setouhy DA; Gamiel AA; Badawi AA; Osman AS; Labib DA
    Pharm Dev Technol; 2017 Mar; 22(2):256-265. PubMed ID: 27494155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.